571 related articles for article (PubMed ID: 6948606)
21. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
Cooper RA; Ip SH; Cassileth PA; Kuo AL
Cancer Res; 1981 May; 41(5):1847-52. PubMed ID: 6938303
[TBL] [Abstract][Full Text] [Related]
23. Accessory function and interleukin 1 production by human leukemic cell lines.
Wakasugi H; Harel A; Dokhelar MC; Fradelizi D; Tursz T
J Immunol; 1984 Jun; 132(6):2939-47. PubMed ID: 6373923
[TBL] [Abstract][Full Text] [Related]
24. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage.
Briggs R; Dworkin L; Briggs J; Dessypris E; Stein J; Stein G; Lian J
J Cell Biochem; 1994 Feb; 54(2):198-206. PubMed ID: 8175894
[TBL] [Abstract][Full Text] [Related]
25. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
26. Functional maturation of membrane potential changes and superoxide-producing capacity during differentiation of human granulocytes.
Kitagawa S; Ohta M; Nojiri H; Kakinuma K; Saito M; Takaku F; Miura Y
J Clin Invest; 1984 Apr; 73(4):1062-71. PubMed ID: 6200501
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells: association with enhanced fragmentation of mature genomic DNA.
Jun CD; Park SJ; Choi BM; Kwak HJ; Park YC; Kim MS; Park RK; Chung HT
Cell Immunol; 1997 Feb; 176(1):41-9. PubMed ID: 9070316
[TBL] [Abstract][Full Text] [Related]
28. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
29. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
30. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
31. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
Atkinson JP; Jones EA
J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
[TBL] [Abstract][Full Text] [Related]
32. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
33. Reversible effects of retinoic acid on glycosaminoglycan synthesis during differentiation of HL-60 leukemia cells.
Reiss M; Maniglia CA; Sartorelli AC
Cancer Res; 1985 May; 45(5):2092-7. PubMed ID: 3857115
[TBL] [Abstract][Full Text] [Related]
34. Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation.
Miller LJ; Schwarting R; Springer TA
J Immunol; 1986 Nov; 137(9):2891-900. PubMed ID: 2428876
[TBL] [Abstract][Full Text] [Related]
35. Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.
Chatterjee D; Han Z; Mendoza J; Goodglick L; Hendrickson EA; Pantazis P; Wyche JH
Cell Growth Differ; 1997 Oct; 8(10):1083-9. PubMed ID: 9342186
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
37. Membrane lipid dynamics in human promyelocytic leukemia cells sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate induction of differentiation.
Fisher PB; Schachter D; Abbott RE; Callaham MF; Huberman E
Cancer Res; 1984 Dec; 44(12 Pt 1):5550-4. PubMed ID: 6594192
[TBL] [Abstract][Full Text] [Related]
38. Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester.
Kufe DW; Griffin J; Mitchell T; Shafman T
Cancer Res; 1984 Oct; 44(10):4281-4. PubMed ID: 6432308
[TBL] [Abstract][Full Text] [Related]
39. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
Lane RW; Sturm RJ; Borzelleca JF; Carchman RA
Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine.
Riscoe MK; Schwamborn J; Ferro AJ; Olson KD; Fitchen JH
Cancer Res; 1987 Jul; 47(14):3830-4. PubMed ID: 3474063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
